Literature DB >> 33257803

Phenotyping of retinal neovascularization in ischemic retinal vein occlusion using wide field OCT angiography.

Josef Huemer1,2, Hagar Khalid1,3, Siegfried K Wagner1, Luke Nicholson1, Dun Jack Fu1, Dawn A Sim1, Praveen J Patel1, Konstantinos Balaskas1, Ranjan Rajendram1, Pearse A Keane4.   

Abstract

BACKGROUND/
OBJECTIVES: Abnormal retinal neovascularization caused by ischemic retinal vein occlusion (RVO) is a frequent cause of visually significant vitreous hemorrhage. The early detection of new vessels may be challenging and often requires the use of invasive tests such as fundus fluorescein angiography (FA). We demonstrate the use of wide-field optical coherence tomography angiography (WF-OCTA) in the detection and characterization of neovascularization secondary to ischemic RVO. SUBJECTS/
METHODS: We conducted a retrospective observational case series of patients diagnosed with ischemic RVO between August 2018 and March 2019, who underwent WF-SS-OCTA imaging (PLEX Elite 9000, Carl Zeiss Meditec). We performed real-life montage imaging, covering the involved area and compared the findings of WF-SS-OCTA to standard clinical examination and when available, ultrawide-field fluorescein angiography (UWF-FA, Optos 200TX).
RESULTS: In the included 39 eyes with ischemic RVO, neovascularization elsewhere (NVE) was encountered in 16 of 39 eyes (41%) on WF-OCTA and were characterized as sea-fan type vessels and nodular type vessels, based on their appearance and localization. NVE was identified in 4/39 eyes on standard clinical examination, equating to a detection rate of 10.3%. All were of a sea-fan morphology. In one case, NVE found on WF-OCTA was not observed on UWF-FA, which was a nodular type. Neovascularization of the disc (NVD) was detected in one eye.
CONCLUSIONS: WF-OCTA may become a useful noninvasive tool in the detection of neovascularization in patients with ischemic RVO. Furthermore, the characterization of different morphologies of neovascularization detected by WF-OCTA could be of clinical relevance.
© 2020. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Entities:  

Mesh:

Year:  2020        PMID: 33257803      PMCID: PMC8452616          DOI: 10.1038/s41433-020-01317-9

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   4.456


  7 in total

1.  New vessel formation in retinal branch vein occlusion.

Authors:  J S Shilling; E M Kohner
Journal:  Br J Ophthalmol       Date:  1976-12       Impact factor: 4.638

2.  The natural course of central retinal vein occlusion.

Authors:  H Zegarra; F A Gutman; J Conforto
Journal:  Ophthalmology       Date:  1979-11       Impact factor: 12.079

Review 3.  Retinal imaging in the twenty-first century: state of the art and future directions.

Authors:  Pearse A Keane; Srinivas R Sadda
Journal:  Ophthalmology       Date:  2014-10-03       Impact factor: 12.079

Review 4.  Fluorescein angiography complication survey.

Authors:  L A Yannuzzi; K T Rohrer; L J Tindel; R S Sobel; M A Costanza; W Shields; E Zang
Journal:  Ophthalmology       Date:  1986-05       Impact factor: 12.079

5.  Panretinal photocoagulation in central retinal vein occlusion: A randomised controlled clinical study.

Authors:  L Laatikainen; E M Kohner; D Khoury; R K Blach
Journal:  Br J Ophthalmol       Date:  1977-12       Impact factor: 4.638

6.  Argon laser scatter photocoagulation in treatment of branch retinal vein occlusion. A prospective clinical trial.

Authors:  S S Hayreh; L Rubenstein; P Podhajsky
Journal:  Ophthalmologica       Date:  1993       Impact factor: 3.250

7.  Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics.

Authors:  S S Hayreh; M B Zimmerman; P Podhajsky
Journal:  Am J Ophthalmol       Date:  1994-04-15       Impact factor: 5.258

  7 in total
  3 in total

Review 1.  Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion.

Authors:  Yi Tang; Yan Cheng; Shuo Wang; Yongjie Wang; Pengjia Liu; Hong Wu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

Review 2.  Progress and Challenges of Anti-VEGF Agents and Their Sustained-Release Strategies for Retinal Angiogenesis.

Authors:  Manhong Xu; Ruiyan Fan; Xiaoe Fan; Yan Shao; Xiaorong Li
Journal:  Drug Des Devel Ther       Date:  2022-09-22       Impact factor: 4.319

3.  Characterizing Flow and Structure of Diabetic Retinal Neovascularization after Intravitreal Anti-VEGF Using Optical Coherence Tomography Angiography: A Pilot Study.

Authors:  Christof Haensli; Katrin Fasler; Daniel Barthelmes; Sandrine A Zweifel
Journal:  J Ophthalmol       Date:  2021-07-14       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.